```html

Quilted Papulosis (Pruritic Papular Eruption)

Overview

Quilted papulosis, also known as pruritic papular eruption (PPE), is a chronic skin disorder characterized by multiple, intensely itchy, flat‑topped papules that often form a “quilt‑like” pattern on the torso and limbs. The condition most frequently appears in children and adolescents living in tropical or subtropical areas, but cases have been reported worldwide.

• Typical age of onset: 5–15 years, though adults can be affected.
• Gender distribution: Slight male predominance (approx. 55 % male).
• Prevalence: Exact global prevalence is unknown because PPE is under‑reported; epidemiological surveys from West Africa estimate a prevalence of 1–2 % among school‑aged children in endemic regions [[1]](https://www.cdc.gov).
• Geography: Most common in sub‑Saharan Africa, the Caribbean, and parts of South‑East Asia where parasitic infestations and poor sanitary conditions are more common.

Symptoms

The clinical picture can vary, but the following symptoms are consistently described in the literature.

Typical skin findings

• Pruritic papules: Small (2–5 mm), erythematous to hyperpigmented, flat‑topped lesions that are intensely itchy.
• “Quilted” arrangement: Papules often coalesce in a reticulated or “staggered” pattern, resembling a quilt or netting on the skin.
• Distribution: Usually symmetric on the trunk (especially the back and abdomen), upper arms, and sometimes the buttocks; sparing the face, palms, and soles.
• Excoriations & secondary infection: Persistent scratching can lead to crusting, scaling, and bacterial colonisation (often Staphylococcus aureus).

Associated symptoms

• Night‑time worsening of itch.
• Sleep disturbance and irritability, especially in children.
• Occasional low‑grade fever if secondary infection develops.
• Rarely, lichenification (thickened skin) in chronic cases.

Causes and Risk Factors

The exact etiology of PPE remains incompletely understood, but several factors are implicated.

Primary hypotheses

• Parasitic hypersensitivity: Many studies link PPE to chronic exposure to ectoparasites (e.g., Pediculus humanus head/body lice, scabies mites). The skin reaction is thought to be an immune response to antigens from the parasites or their feces [[2]](https://www.mayoclinic.org).
• Environmental allergens: Dust mites, mold spores, and certain plant pollens may act as triggers in predisposed individuals.
• Immune dysregulation: Elevated serum IgE and Th2‑type cytokine profiles have been reported, suggesting a atopic‑like pathway.

Risk factors

• Living in crowded or low‑hygiene conditions where lice or scabies are common.
• Concurrent atopic disease (e.g., eczema, allergic rhinitis).
• Age < 16 years (immature immune regulation).
• Family history of pruritic skin disorders.
• Limited access to regular dermatologic care.

Diagnosis

Diagnosis is primarily clinical, supported by a focused history and, when needed, laboratory studies to rule out mimickers.

Step‑by‑step approach

1. History taking: Duration of rash, itch pattern, exposure to lice/scabies, travel history, and any atopic conditions.
2. Physical examination: Look for the characteristic quilt‑like papular pattern, distribution, and secondary changes.
3. Dermatoscopy (optional): May reveal central punctum or subtle scaling that supports a parasitic cause.
4. Skin scrapings: Microscopic examination for scabies mites, eggs, or lice nits if infestation is suspected.
5. Allergy testing: Patch testing or serum specific IgE can be considered if allergic triggers are suspected.
6. Biopsy (rarely needed): Histology shows a superficial perivascular lymphocytic infiltrate with eosinophils, helping to exclude psoriasis or lichen planus.

Conditions to rule out

• Scabies
• Papular urticaria
• Atopic dermatitis
• Psoriasis (especially guttate type)
• Drug‑induced eruptions

Treatment Options

Treatment aims to relieve itch, eradicate any underlying parasitic cause, and prevent secondary infection. A multimodal plan is usually most effective.

1. Addressing parasites

• Lice: 1% permethrin shampoo applied to the scalp and body, repeated in 7‑10 days per CDC guidelines [[3]](https://www.cdc.gov/parasites/lice).
• Scabies: 5% permethrin cream applied overnight to the entire body, repeated after 7 days; oral ivermectin 200 µg/kg as a single dose may be used in resistant cases.

2. Anti‑inflammatory and antipruritic medications

• Topical corticosteroids: Low‑ to mid‑potency (e.g., 0.1% triamcinolone) applied twice daily for 2–3 weeks reduces inflammation.
• Topical calcineurin inhibitors: 0.1% tacrolimus or 1% pimecrolimus are steroid‑sparing options, especially for sensitive skin areas.
• Oral antihistamines: Non‑sedating (cetirizine 10 mg daily) for daytime itch; sedating agents (diphenhydramine) at night to improve sleep.
• Systemic steroids: Short courses (prednisone 0.5 mg/kg for ≤7 days) reserved for severe flares.

3. Treating secondary infection

• Topical mupirocin or fusidic acid for localized bacterial infection.
• Oral antibiotics (e.g., cephalexin 500 mg q6h for 7 days) if cellulitis develops.

4. Adjunctive measures

• Emollients: Thick moisturizers (e.g., petroleum jelly, ceramide‑rich creams) applied immediately after bathing to restore barrier function.
• Wet‑wrap therapy: For refractory itch—apply a moisturizer, cover with damp gauze, then a dry layer for 2‑4 hours.
• Behavioural techniques: Habit‑reversal training and stress‑management can reduce scratching.

Living with Quilted Papulosis (Pruritic Papular Eruption)

Chronic skin conditions can affect quality of life. Below are practical strategies to help patients and families manage day‑to‑day.

• Maintain a consistent skin‑care routine: Shower with lukewarm water, use fragrance‑free cleansers, and apply emollient within 3 minutes of drying.
• Keep nails short: Reduces skin damage from scratching.
• Clothing choices: Soft, breathable fabrics (cotton, bamboo) minimize irritation; avoid wool or synthetic fibers that trap heat.
• Environmental control: Wash bedding weekly at 60 °C, vacuum carpets regularly, and use dust‑mite–proof covers.
• School accommodations: Arrange for a nurse or teacher to assist with medication application and to allow short breaks for itch relief.
• Track flare‑ups: A simple diary noting date, severity, possible triggers, and treatment response can aid clinician‑patient communication.
• Psychosocial support: Referral to a psychologist or support group is valuable when itching interferes with sleep, school, or self‑esteem.

Prevention

Because many cases are linked to parasitic exposure, prevention focuses on hygiene and environmental measures.

• Regular head‑and‑body checks for lice in schools and households; prompt treatment of infestations.
• Prompt treatment of scabies and close contacts.
• Maintain clean living conditions: frequent laundering of clothes and bed linens, regular cleaning of shared spaces.
• Use insect‑repellent clothing in endemic regions during peak seasons.
• Educate caregivers about early signs of itching and the importance of seeking dermatologic evaluation.

Complications

While PPE itself is not life‑threatening, complications can arise when the condition is left untreated or poorly managed.

• Secondary bacterial infection: Excoriation creates portals for bacteria, leading to impetigo, cellulitis, or abscess formation.
• Chronic lichenification: Long‑standing scratching can thicken the skin, making lesions more resistant to therapy.
• Sleep deprivation and psychosocial impact: Persistent itch can cause fatigue, poor academic performance, and anxiety or depression.
• Scarring: Deep scratching may cause permanent pigment changes or atrophic scars.

When to Seek Emergency Care

---

References

1. World Health Organization. WHO Fact Sheets on Skin NTDs. 2023.
2. Mayo Clinic. “Scabies.” Accessed June 2026.
3. Centers for Disease Control and Prevention. “Pediculosis (Head Lice).” Accessed June 2026.
4. Cleveland Clinic. “Pruritic Papular Eruption (PPE).” Patient Education Handout, 2022.
5. National Institute of Allergy and Infectious Diseases. “Atopic Dermatitis and Eosinophilia.” NIH, 2021.

```